Metallokinetic Study of Zinc in the Blood of Normal Rats Given Insulinomimetic Zinc(II) Complexes and Improvement of Diabetes Mellitus in Type 2 Diabetic GK Rats by their Oral Administration

Drug Metabolism and Pharmacokinetics

Volumn 17, Issue 4, 2002, Pages 340-347

  Fugono, Jun ^a   Fujimoto, Keisuke ^a   Yasui, Hiroyuki ^a   Kawabe, Kenji ^a   Yoshikawa, Yutaka ^a   Kojima, Yoshitane ^a   Sakurai, Hiromu ^a  

^a KYOTO PHARMACEUTICAL UNIVERSITY   (Japan)

Author keywords

GK rat; pharmacokinetic study; type 2 diabetes mellitus; zinc

Indexed keywords

EID: 2542465510     PISSN: 13474367     EISSN: 18800920     Source Type: Journal    
DOI: 10.2133/dmpk.17.340     Document Type: Article

References (25)

1. Sakurai, H., Kojima, Y., Yoshikawa, Y., Kawabe, K. and Yasui, H.: Antidiabetic vanadium(IV) and zinc(II) complexes. Coord. Chem. Rev., 226: 187-198 (2002).
2. Subasinghe, S., Greenbaum, A. L. and McLean, P.: The insulin-mimetic action of Mn2+: Involvement of cyclic nucleotides and insulin in the regulation of hepatic hexokinase and glucokinase. Biochem. Med., 34: 83-92 (1985).
3. Saker, F., Ybarra, J., Leahy, P., Hanson, R. W., Kalhan, S. C. and Ismail-Beigi, F.: Glycemia-lowering eŝect of cobalt chloride in the diabetic rat: role of decreased gluconeogenesis. Am. J. Physiol., 274: E984-E991 (1998).
4. Battell, M. L., Delgatty, H. L. and Mcneill, J.H.: Sodium selenate corrects glucose tolerance and heart function in STZ diabetic rats. Mol. Cell. Biochem., 179: 27-34 (1998).
5. Yoshikawa, Y., Ueda, E., Miyake, H., Sakurai, H. and Kojima, Y.: Insulinomimetic bis(maltolato) zinc(II) complex: blood glucose normalizing eŝect in KK-A(y) mice with type 2 diabetes mellitus. Biochem. Biophys. Res. Commun., 281(5): 1190-1193 (2001).
6. Ueda, E., Yoshikawa, Y., Ishino, Y., Sakurai, H. and Kojima Y.: Potential insulinomimetic agents of zinc(II) complexes with picolinamide derivatives: preparations of complexes, in vitro and in vivo studies. Chem. Pharm. Bull., 50(3): 337-340 (2002).
7. Yoshikawa, Y., Ueda, E., Kawabe, K., Miyake, H., Takino, T., Sakurai, H. and Kojima, Y.: Development of new insulinomimetic zinc(II) picolinate complexes with a Zn(N2O2) coordination mode: structure characterization, in vitro, and in vivo studies. J. Biol. Inorg. Chem., 7: 68-73 (2002).
8. Cusi, K., Cukier, S., DeFronzo, R. A., Torres, M., Puchulu, F. M. and Pereira, R. J. C.: Vanadyl sulfate improves hepatic and muscle insulin sensitivity in type 2 diabetes. J. Clin. Endocrinol. Metab., 86: 1410-1417 (2001).
9. Fugono, J., Yasui, H. and Sakurai, H.: Pharmacokinetic study on gastrointestinal absorption of insulinomimetic vanadyl complexes in rats by ESR spectroscopy. J. Pharm. Pharmacol., 53: 1247-1255 (2001).
10. Fugono, J., Yasui, H. and Sakurai, H.: Enteric-coating capsulation of insulinomimetic vanadyl sulfate enhances bioavailability of vanadyl species in rats. J. Pharm. Pharmacol., in press (2002).
11. Goto, Y., Kakizaki, M. and Masaki, N.: Spontaneous diabetes produced by selective breeding of normal Wistar rats. Proc. Jpn. Acad., 51: 80-85 (1975).
12. Goto, Y., Suzuki, K., Sasaki, M., Ono, T. and Abe, S.: GK rats as a model of non-obese, non-insulin-dependent diabetes: selective breeding over 35 generations. In Frontiers in diabetes research. Lessons from animal diabetes. II.: 301-303 (1988).
13. Portha, B., Serradas, P., Bailbe, D., Suzuki, K., Goto, Y. and Giroix, M. H.: b-Cell insensitivity to glucose in the GK rats, a spontaneous nonobese model for type II diabetes. Diabetes., 40: 486-491 (1991).
14. Yamaoka, K., Nakagawa, T. and Uno, T.: Statistical moment in pharmacokinetics. J. Pharmacokinet. Biopharm., 6: 547-558 (1978).
15. Ookawara, T., Kawamura, N., Kitagawa, Y. and Taniguchi, N.: Site-specîc and random fragmentation of Cu, Zn-superoxide dismutase by glycation reaction. J. Biol. Chem., 267(26): 18505-18510 (1992).
16. Schwarz, K. and Mertz, W.: Chromium (III) and the glucose tolerance factor. Arch Biochem. Biophys., 85: 292-295 (1959).
17. Tuvemo, T., Ewald, U., Kobbah, M. and Proos, L. A.: Serum magnesium and protein concentrations during thêrst Hňve years of insulin-dependent diabetes in children. Acta Paediatr. Suppl., 418: 7-10 (1997).
18. Paolisso, G., Scheen, A., Cozzolino, D., Maro, G. D., Varricchio, M., D‚onofrio, F. and Lefebvre, P. J.: Changes in glucose turnover parameters and improvement of glucose oxidation after 4-week magnesium administration in elderly noninsulin-dependent (type II) diabetic patients. J. Clin. Endocrinol. Metab., 78: 1510-1514 (1994).
19. Coulston, L. and Dandona, P.: Insulin-like eŝect of zinc on adipocytes. Diabetes., 29: 665-667 (1980).
20. Chen, M. D., Song, Y.M. and Lin, P. Y.: Zinc may be a mediator of leptin production in humans. Life Sci., 66(22): 2143-2149 (2000).
21. Barrie, S. A., Wright, J. V., Pizzorno, J. E., Kutter, E. and Barron, P. C.: Comparative absorption of zinc picolinate, zinc citrate and zinc gluconate in humans. Agents and Actions., 21: 223-228 (1987).
22. Hider, R.C., Ejim, L., Taylor, P.D., Gale, R., Huehns, E. and Porter, J. B.: Facilitated uptake of zinc into human erythrocytes. Biochem. Pharmacol., 39(6): 1005-1012 (1990).
23. Sakurai, H., Fujii, K., Watanabe, H. and Tamura, H.: Orally active and long-term acting insulin-mimetic vanadyl complex: bis(picolinato)oxovanadium. Biochem. Biophys. Res. Commun., 214: 1095-1101 (1995).
24. Fujimoto, S., Fujii, K., Yasui, H., Matsushita, R., Takada, J. and Sakurai, H.: Long-term acting and orally active vanadyl-methylpicolinato complex with hypoglycemic activity in streptozotocin-induced diabetic rats. J. Clin. Biochem. Nutr., 23: 113-129 (1997).
25. Salgueiro, M. J., Zubillaga, B. M. B., Lysionek, A. E., Sarabia, M. I., Caro, R.A., Paoli, T., Hager, A., Ettlin, E., Weill, R. and Boccio, J. R.: Bioavailability, biodistribution, and toxicity of BioZn-AAS: a new zinc source. Comparative studies in rats. Nutrition., 16: 762-766 (2000).